Biotechnology Industry News

The global next-generation sequencing market is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years. The advanced research and development activities by the major players are propelling the demand for cost effective and efficient next-generation sequencing platforms. However, interpretation of large volume of complex sequencing data through next-generation sequencing platforms is a major challenge in global next-generation sequencing market. Access Report Overview: https://www.psmarketresearch.com/market-analysi

The global forensic technologies market is growing significantly due to increasing rate of crime across the globe, technological advancements in forensic techniques, and increasing number of forensic laboratories. In addition, increasing demand and awareness for DNA testing are supporting growth of global forensic technologies market. Outsourcing of crime cases by government laboratories to privately held laboratories is creating ample opportunities for private players in global forensic technologies market. Moreover, increasing number of crime cases along with lack of service providers are creating abundant opportunities for the global forensic technologies market to grow at a considerable rate in the coming years. The advanced research and development of new products and technologies by the major players are propelling the demand for cost effective and efficient forensic techniques. Some of the factors driving the growth of the global forensic technologies market are increas

Cell-based assays are commonly used analytical tools to measure the cell proliferation, viability, cytotoxicity, production and screening of compounds. Owing to the rise in cases of chronic disorders and increasing inclination of the government organizations and private firms funding in the health sector, there has been a consistent high demand of new therapeutic drug discovery. In this regard, the cell-based assays have advantage over the conventional animal based models for drug discovery. Cell-based assays utilizes live cell models to investigate the cellular mechanism when exposed to external stimuli and provide precise information about the intracellular molecular targets required in drug discovery screening.  In contrary to the animal based methods, the resultant toxicity and safety measures in cell based assays are monitored at an early stage of an experiment, hence it reduces the additional cost that can be generated due to high failure rates if monitored at a later stage of

Membrane technology refers to all engineering advancements for transporting substances between two fractions by the use of permeable membranes. Generally, mechanical separation processes use membrane technology for separating gaseous or liquid streams. Membrane technology is used in a range of development phases of pharmaceutical, life sciences and biopharmaceutical industries. Membrane technology has applications in laboratory drug research, large scale pharmaceutical production, lab scale DNA and protein separation, cell culturing, drug screening, and examination and virus removal. Some of the major products of membrane technology are microarray products, syringe membranes filters, multi-well filters and bottle top filters. Membrane technology has observed incredible development and transformations in technology, system and efficiency over the last few decades. Diminishing fresh water sources, drought sources, water pollution, and constantly growing population across the g

Rising demand of disposables in biopharmaceutical production, increasing prevalence of chronic diseases, which requires biological drugs for their management and treatment, low manufacturing costs of disposable products and instrument, and improving life science research infrastructure are some of the growth drivers of the global single-use bioprocessing systems market. In addition, technological advancement in bioprocessing systems is also driving the growth of global single-use bio-processing systems market. Increasing numbers of mergers and acquisitions and rapid product launches are some of the major trends, observed in the global single-use bioprocessing systems market. Europe and North America are the major markets for single-usebioprocessing systems , attributed to the increased life science research and growing demand for biopharmaceuticals. Asia-Pacific market for the single-use bioprocessing systems is growing at a significant rate owing to improving life science

  The cell and tissue culturesupplies market is growing at a significant rate due to rising applications of the cell and tissue cultures, increasing research and development in the area of cell and tissue engineering, and increasing demand for biopharmaceuticals and artificial organs. Increasing popularity of contract research, serum-free, specialty, and customized media solutions are further supporting the cell and tissue culture supplies market to grow in the coming years. North America dominates the cell and tissue culture supplies market due to advancement in cell culture tools. Additionally, rise in demand for animal component free media and automated cell culture systems are some of the factors leading to increased demand of cell and tissue culture supplies in the region. Europe is the second largest market of cell and tissue culture supplies due to increase in demand of cell culture supplies by biotechnology companies, pharmaceutical industries and cell culture research

Blood plasma product is the extracted portion from the blood using fractionation process to deliver products rich in plasma proteins. These products are used as body fluids, antibodies and clotting factors in medical industries that aid in treatment of chronic ailments like auto-immune disorders and haemophilia. The global blood plasma product market is expected to witness a significant growth during the forecast period due to the high demand by a large pool of patients with no alternative therapeutic approach. Blood plasma product have a wide range of components that have clinical use such as, Albumin, Factor VIII, Factor IX, immunoglobulin, fibrinogen with their major applications in bleeding disorders (haemophilia, immunological disorders), massive hemorrhage and in traumatic injuries. Moreover, the presence of biomarkers in plasma adds to their application in clinical diagnosis of diseases. These factors will drive the growth of global blood plasma product market in future.

Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell. Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group. The global blood group typingmarket has witnessed significant growth due to the advancement in technology which has improved detection methods. Blood group typing can be done via various tests namely, antigen typing, cross-matching tests, antibody screening, human leukocyte antigen (HLA) typing and ABO blood tests. Among the different blood group typing tests, antibody screening is expected to witness the fastest growth in the global market during the forecast period. Rising demand for early